.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Cerilliant
US Department of Justice
Healthtrust
Fuji
Dow
Medtronic
Queensland Health
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Patents Expiring in 2036

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Silvergate PharmsEPANEDenalapril maleateSOLUTION;ORAL208686-001Sep 20, 2016RXYesYes➤ Sign Up➤ Sign UpY
Silvergate PharmsEPANEDenalapril maleateSOLUTION;ORAL208686-001Sep 20, 2016RXYesYes➤ Sign Up➤ Sign UpMETHOD OF TREATING HYPERTENSION
Silvergate PharmsEPANEDenalapril maleateSOLUTION;ORAL208686-001Sep 20, 2016RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF HYPERTENSION
Silvergate PharmsEPANEDenalapril maleateSOLUTION;ORAL208686-001Sep 20, 2016RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF HEART FAILURE
Silvergate PharmsEPANEDenalapril maleateSOLUTION;ORAL208686-001Sep 20, 2016RXYesYes➤ Sign Up➤ Sign UpMETHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION
Silvergate PharmsEPANEDenalapril maleateSOLUTION;ORAL208686-001Sep 20, 2016RXYesYes➤ Sign Up➤ Sign UpMETHOD OF TREATMENT OF HEART FAILURE
AstrazenecaCALQUENCEacalabrutinibCAPSULE;ORAL210259-001Oct 31, 2017RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF ADULT PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY
Corcept TherapKORLYMmifepristoneTABLET;ORAL202107-001Feb 17, 2012RXYesYes➤ Sign Up➤ Sign UpTREATING CUSHING'S SYNDROME
Collegium Pharm IncXTAMPZA ERoxycodoneCAPSULE, EXTENDED RELEASE;ORAL208090-001Apr 26, 2016RXYesNo➤ Sign Up➤ Sign UpYMANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE.
Collegium Pharm IncXTAMPZA ERoxycodoneCAPSULE, EXTENDED RELEASE;ORAL208090-005Apr 26, 2016RXYesYes➤ Sign Up➤ Sign UpYMANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE.
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
US Army
Citi
Healthtrust
Queensland Health
Merck
Harvard Business School
McKinsey
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot